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AbstrAct
Background: The prevalence of chronic kidney disease (CKD) is high in sub-Saharan Africa and affects the productive 
workforce. CKD has been associated with psychological problems such as anxiety and depression; however, there is 
little published information on the burden of psychological problems among the CKD population in African countries. 
Our study assessed psychological changes in two groups of patients, one group with end-stage renal disease receiving 
chronic haemodialysis, and a second with CKD not on dialysis.
Methods: A cross-sectional study involving patients on chronic haemodialysis and patients with CKD stages 3–5 (the 
“CKD” patients) was conducted at the Renal Unit of the Korle-Bu Teaching Hospital in Accra, Ghana.  One hundred 
and sixty-eight participants (82 CKD and 86 haemodialysis patients) were recruited.  Demographic, clinical and 
laboratory information was captured, the Revised Quick Cognitive Screening Test (RQCST) was used to assess 
cognitive function and the Brief Symptoms Inventory-18 (BSI-18) was used to screen for anxiety, somatization 
and depression.
Results: CKD patients were older than those on haemodialysis, with mean ages of 53.3 and 46.6 years, respectively. 
Two-thirds (113/167) were male. The median glomerular filtration rate (GFR) of the CKD patients was 21 mL/
min/1.73 m2 (interquartile range 9–34). Most of the haemodialysis patients (78.6%) were receiving two sessions 
of haemodialysis per week and their mean kT/V was 1.16 ± 0.23. The RQCST global scores in the two groups of 
patients were similar, with almost 90% of haemodialysis patients and 85% of CKD patients obtaining scores 
above 50. Haemodialysis patients had better scores for immediate recall memory. The haemodialysis patients also 
had higher BSI-18 global scores than the CKD patients (mean of 0.83 vs 0.70, p = 0.033). Mean anxiety and 
somatization scores were also higher in the haemodialysis patients. 
Conclusions: Haemodialysis patients demonstrated higher anxiety and somatization scores than the CKD patients. 
Clinical psychological support should therefore be included in the treatment of our patients, and especially for those 
on chronic haemodialysis. 
Keywords: chronic kidney disease; haemodialysis; psychological profile; cognitive function; sub-Saharan Africa; Ghana; 
depression.
Psychological problems such as impaired cognitive func-
tioning, anxiety and depression are common in patients 
with CKD [4,5]. The prevalence of anxiety is high among 
haemodialysis patients and also in those with CKD who 
are not being treated with dialysis (the “CKD” patients), 
INtrODUctION
In Ghana, the prevalence of chronic kidney disease 
(CKD) is estimated to be 13% [1]. CKD affects mainly 
younger adults in sub-Saharan Africa (SSA) [2] whereas 
in developed countries the disease burden is highest in 
those aged 60 years and above [3]. 
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with rates as high as 52% and 54%, respectively. Psychological 
symptoms affect quality of life, and are associated with 
faster progression of CKD and higher rates of morbidity 
and mortality [4,5]. 
Risk factors for psychological problems in dialysis patients 
include financial difficulties, frequent hospitalization, restric-
tion of leisure time and uncertainty about the future, among 
others [3-5]. Patients with advanced CKD develop uraemia, 
which contributes to impaired cognitive function [6] and 
this negatively impacts on treatment compliance leading to 
poor outcomes [7]. 
Most of the studies of psychological problems in CKD or 
dialysis patients have been conducted in developed 
countries, where patients are mostly elderly. Studies in 
Africans with CKD are scarce. The study reported here 
assessed the psychological changes and predictors of 
cognitive deficits in Ghanaian patients with CKD and those 
with end-stage renal disease (ESRD) who were being 
treated with chronic haemodialysis. 
MEtHODs
A cross-sectional study was conducted at the outpatient 
clinics and haemodialysis centre of the Renal Unit of Korle-
Bu Teaching Hospital. This is the third-largest hospital 
in Africa and the leading national referral centre in Ghana. 
It has an average daily attendance of 1,500 patients and 
about 300 patient admissions a day. The Renal Unit has 
18 haemodialysis machines and provides treatment for 
approximately 260 patients with ESRD. Kidney trans-
plantation services are also provided.
A total of 168 adult patients (82 CKD stages 3–5 and 86 
haemodialysis patients) were recruited by convenience 
sampling from April 2014 to October 2016. Those with 
dementia, stroke, head injury or Parkinson’s disease were 
excluded. All participants provided voluntary written 
informed consent. 
A structured data sheet was used to collect socio-
demographic and clinical information, including data on co-
morbidities and details related to the dialysis treatment 
(frequency, duration, funding). For CKD patients, the CKD-
EPI equation was used to estimate glomerular filtration 
rate (eGFR) from serum creatinine [8]. The adequacy of 
haemodialysis was determined using kT/V, with a value of 
>1.2 considered adequate [9].
The Revised Quick Cognitive Screening Test (RQCST) and 
the Brief Symptoms Inventory-18 (BSI-18) were used for 
psychological measures. The RQCST measures various 
cognitive domains including orientation, attention and 
concentration, memory, language, arithmetic, constructional 
apraxia, perceptual reasoning, spatial ability, and abstract 
reasoning. It generates four main scores: orientation, verbal, 
visual/nonverbal, and a global score which is the sum of 
the first three. A global score of 50 or above indicates 
normal cognitive functioning and a score below 50 signifies 
impaired cognitive functioning. Internal consistency reli-
ability coefficients of 0.78, 0.84, 0.84 and 0.92 have been 
reported for the orientation, verbal, visual and global 
scores, respectively [10]. 
The BSI-18 is designed to screen for psychological dis- 
tress [11]. It measures three aspects of distress, namely, 
somatization, depression and anxiety. 
Data were analysed using Stata version 14.1. Descriptive 
statistics including frequencies, percentages, means (with 
standard deviations) and medians (with interquartile 
ranges) were determined. Differences between the two 
patient groups were examined using the chi-squared test 
for categorical variables, and Welch’s t-tests or Mann–
Whitney tests for numerical variables. Simple linear 
regression was used to identify explanatory variables to be 
considered for multiple linear regression for the main 
outcome, namely, cognitive function as measured with the 
RQCST global score. P values of <0.05 were considered 
statistically significant. 
Ethical clearance was obtained from the Ethical and 
Protocol Review Committee of the College of Health 
Sciences, University of Ghana, with identification number 
MS-Et/M.5–P3.2/2012-2013. 
rEsULts
Baseline characteristics and scores on the psychological 
assessments are summarized in Table 1. Of the 167 
patients, two-thirds (113/167) were male. The CKD 
patients were older than those on haemodialysis, with 
median ages of 53.3 and 46.6 years, respectively. The 
median eGFR of the CKD patients was 21 mL/min/1.73 m2 
(interquartile range 9–34).  Among the CKD patients, the 
proportion of patients at stage 5 was 35.8%.  Approximately 
two-thirds of the patients had national health insurance. 
Most of the haemodialysis patients (58.8%) were unem-
ployed with more than half of them having stopped work 
due to their condition. The majority received two dialysis 
sessions per week and for most the duration of each 
session was three-and-a-half hours. The mean kT/V was 
1.16. Dialysis treatments were funded by patients and their 
families/friends, through charitable donations, by non-
governmental organizations, employers, or the church. 
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table 1. Characteristics of CKD and haemodialysis patients at the Korle-Bu Teaching Hospital. Reported as mean ± SD, numbers (%) 
and median (IQR).
Haemodialysis (n = 86) 
Frequency (%)
CKD (n = 81) 
Frequency (%) P-value
Age (years) 46.6 ± 14.6 53.3 ± 16.2 0.006
  18–39 28 (32.6) 18 (22.2) 0.075
  40–60 41 (47.7) 35 (43.2)
  60+ 17 (19.8) 27 (33.3)
  Missing - 1 (1.2)
Gender 0.704
  Male 59 (68.6) 54 (65.8)
  Female 27 (31.4) 28 (34.2)
Educational level 0.108
  None 3 (3.5) 7 (8.6)
  Primary/JHS 16 (18.6) 21 (25.9)
  SHS/Vocational/Technical 32 (37.2) 24 (29.6)
 Tertiary 35 (40.7) 26 (32.1)
  Missing - 3 (3.7)
eGFR - 21 (8–34)
Dialysis frequency/week 
  2 sessions 66 (76.7)
  3 sessions 18 (20.9)
  Missing 2 (2.3)
Dialysis duration (hours)
  ≤3 2 (2.3)
  3.5 64 (74.4)
  4 18 (20.9)
  Missing 2 (2.3)
Dialysis adequacy (kT/V) 1.2 ± 0.2
Funding of dialysis 
  Self 27 (31.4)
  Company 17 (19.8)
  Spouse/parent 14 (16.3)
  Other* 25 (29.1)
  Missing 3 (3.5)
National Health Insurance 0.051
 Yes 61 (70.9) 64 (79.0)
  No 23 (26.7) 10 (12.4)
  Missing 2 (2.3) 7 (8.6)
Number of medications 3.6 ± 2.6 4.4 ± 1.9 0.063
Family support
 Yes 53 (61.6)
  No 29 (33.7)
  Missing 4 (4.7)
Global RQCST score 65.8 ± 10.4 63.0 ± 10.7 0.094
BSI-18 General Severity Index 0.8 ± 0.1 0.6 ± 0.1 0.033
  Anxiety score 0.3 (0.0–1.0) 0.2 (0.0–0.7) 0.049
  Somatization score 0.8 (0.5–1.5) 0.7 (0.3–1.1) 0.037
  Depression score 0.7 ± 0.8 0.6 ± 0.6 0.124
JHS, junior high school; SHS, senior high school.  *Donations from friends, NGOs, employers, churches, etc.23
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The RQCST global scores in the two groups of patients 
were similar, with almost 90% of haemodialysis patients 
and 85% of CKD patients obtaining scores above 50. 
Haemodialysis patients had better scores for immediate 
recall memory (Table 4). These patients had higher mean 
BSI-18 global scores than the CKD patients (0.8 ± 0.1 vs 0.7 
± 0.1, p = 0.033). Mean anxiety and somatization scores 
were also higher in the haemodialysis patients (Table 1). 
From the multivariable analyses for CKD patients (Table 2), 
educational level and number of medications were pre-
dictive of global score. Participants with higher levels of 
education had higher scores than those with no formal 
education. Additional numbers of medications taken were 
associated with lower global scores (Table 2).
Among haemodialysis patients, the multivariable analyses 
revealed educational level, duration of dialysis and 
somatization scores to be predictive of RQCST global 
scores (Table 3). Higher levels of education and longer 
duration of dialysis sessions were associated with higher 
scores, whereas higher somatization scores were predictive 
of lower global scores.
DIscUssION
This study revealed good cognitive function, as assessed by 
RQCST global scores, in almost 90% of our patients. There 
were no differences in the global scores of the haemo-
dialysis and CKD groups; however, the haemodialysis 
patients had better immediate recall memory. This is in line 
with other studies, which reported that short-term memory 
improves on haemodialysis [12] and which found no overall 
differences between patients with CKD and those on 
haemodialysis [13]. 
Factors associated with cognitive function were educa-
tional status and hours per session of haemodialysis. Other 
studies in haemodialysis patients have reported that 
patients with lower educational status have a greater 
likelihood of global cognitive impairment [14,15]. Our 
patients who had 3.5–4 hours of dialysis per session had 
higher RQCST scores than those receiving 3 hours or 
less per session. Another study, comparing 2-hour daily 
haemodialysis with conventional haemodialysis for 4 
hours thrice weekly, did not show any differences in 
cognitive function [16]. Most studies have indicated no 
clear association between duration of haemodialysis ses-
sions and cognitive function [15,16,26]. One investigation, 
however, found that achieving greater haemodialysis 
adequacy (kT/V > 1.2) was associated with increased risk 
of cognitive impairment [27].
In our study, haemodialysis patients had higher mean BSI-
18 global scores than CKD patients. There was no asso-
ciation between depression and cognitive function. Other 
studies using the same scales have demonstrated that 
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table 2. Multiple linear regression illustrating the association of socio-demographic and clinical characteristics on cognitive function 
measured by global RQCST score among non-dialysis CKD patients.
ß 95% CI P-value
Age (years)
  18–39 ref 0.508
  40–60 –1.3 (–6.6–3.9)
  60+ -3.6 (–9.9–2.7)
Educational level
  None ref 0.009
  Primary/JHS 4.7 (–4.7– -13.9)
  SHS/Vocational/Technical 6.8 (–2.8– -16.0)
  Tertiary 12.6 (3.5–21.6)
No National Health Insurance 1.6 (–3.2–6.3) 0.521
Number of medications -1.2 (–2.3– -0.1) 0.032
Somatization score -0.9 (–3.8–1.9) 0.514
JHS, junior high school; SHS, senior high school; ref, the reference category; ß, coefficient of the regression model.
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haemodialysis patients were more likely to develop depres-
sion than pre-dialysis CKD patients [17]. Another study, 
which used the nine-item PHQ questionnaire for depres-
sion, showed haemodialysis to be a significant predictor of 
depression [18]. We found that haemodialysis patients 
had higher scores for anxiety and somatization compared 
to CKD patients.
The prevalence of anxiety is reported to be high among 
haemodialysis patients, ranging from 27% to 52% [14,19,20]. 
High rates of anxiety have also been reported for patients 
with CKD [4]. These results differ from our findings, which 
may be due to differences in study population and the 
tools used to assess anxiety. Furthermore, anxiety has 
been shown to be a predictor of depression, poor quality 
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table 3. Multiple linear regression illustrating the association of socio-demographic and clinical characteristics on cognitive function 
measured by global RQCST score among haemodialysis patients.
ß 95% CI P-value
Age (years)
  18–39 ref 0.094
  40–60 –4.3 (–8.2–-0.4)
  60+ –2.2 (–7.8–3.3)
Educational level
  None ref 0.001
  Primary/JHS 3.7 (–9.8–17.1)
  SHS/Vocational/Technical 10.6 (–3.2–24.4)
  Tertiary 15.6 (1.6–29.7)
Dialysis duration (hours)
  ≤ 3 ref 0.004
  3.5 4.5 (–4.2–13.1)
  4 11.7 (3.2–20.1)
Funding of dialysis
  Self ref 0.122
  Company 6.1 (–0.1–12.3)
  Spouse/partner –0.5 (–5.7–4.7)
  Other –1.2 (–6.9–4.5)
Anxiety score 2.7 (–0.7–6.0) 0.116
Somatization score –4.5 (–7.7–  –1.3) 0.007
Depression
  Never ref 0.477
  A little –0.6 (–4.4–3.3)
  Moderate –0.4 (–8.7–7.9)
  Quite a bit –7.0 (–20.7–6.6)
  Extreme –7.4 (–18.1–3.4)
JHS, junior high school; SHS, senior high school; ref, the reference category; ß, coefficient of the regression model.
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of life, and faster rates of CKD progression [4], which may 
worsen the prognosis of these patients. These psychological 
challenges may lead to adverse outcomes such as poor 
quality of life and higher mortality rates. There is therefore 
a case for collaboration with clinical psychologists in the 
management of these patients, who should be screened 
for depression, anxiety and somatization as early detection 
and interventions may improve their treatment and help to 
prevent adverse outcomes.
Taskapan et al. reported a prevalence rate of 33% of 
somatoform disorders in 40 haemodialysis patients [11,21]. 
Somatization disorder is a predictor of poor quality of life 
[22] and may manifest as headaches, back pain, problems 
with sleep, stomach upset, and chronic tiredness [23,24], as 
also observed in our study.
In Africa, the cost of treatment is a source of anxiety for 
many patients [25]. The majority of our patients, or their 
relatives, funded their haemodialysis treatment. Many 
patients were on the national health insurance scheme, but 
the scheme does not cover chronic haemodialysis. 
Our study has some limitations. It did not explore the 
effects of anxiety and somatization on long-term clinical 
outcomes. In addition, many potential factors which 
influence the occurrence of psychological problems, such 
as poor nutrition, socio-economic factors and co-morbid 
disease, were not assessed. Future studies should include 
the evaluation of all these factors. 
cONcLUsIONs
The CKD and haemodialysis populations in Ghana appear 
to have good overall cognitive function. However, they are 
at risk of anxiety, depression and somatization disorders. 
Psychological evaluation and support should therefore be 
included in the routine management of patients with CKD 
or ESRD.
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